Prof. Dr. Luitpold Distel


Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 7 Go to next page Go to last page

Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2019). Influence of the Kinase Inhibitor Palbociclib on the Migration of malignant and non-malignant Cells under Irradiation. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S171-S171). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Schuster, B., Schenker, H., Fietkau, R., & Distel, L. (2019). Patients with Lupus Erythematosus often have increased Radiosensitivity. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S81-S82). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Echarti, A., Hecht, M., Fietkau, R., & Distel, L. (2019). Prognostic Importance of the CD8-based Immune Status Inflamed, immune-Excluded, and immune Desert in Head and Neck Cancer Patients can be further subdivided by regulatory T Cells. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S44-S44). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Schenker, H., Schuster, B., Fietkau, R., & Distel, L. (2019). Scleroderma and Radiation Sensitivity. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S97-S97). Munster, DE: HEIDELBERG: SPRINGER HEIDELBERG.
Stritzelberger, J., Distel, L., Buslei, R., Fietkau, R., & Putz, F. (2018). Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine. Clinical & Translational Oncology, 20(4), 508-516.
Klein, S., Wegmann, M., Distel, L., Neuhuber, W., & Kryschi, C. (2018). APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy. Biochemical and Biophysical Research Communications, 498(4), 855-861.
Hoffmann, C., Distel, L., Knippen, S., Gryc, T., Schmidt, M., Fietkau, R., & Putz, F. (2018). Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance. Neuro-Oncology, 20(2), 268-278.
Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C.,... Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118(6), 785-792.
Hecht, M., Harrer, T., Koeber, V., Sarpong, E.O., Moser, F., Fiebig, N.,... Distel, L. (2018). Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. Oncology Letters, 15(2), 1728-1736.
Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2018). Effect of the kinase-inhibitor Palbociclib on radio-therapeutic treatment in a 3D cell culture model. (pp. 46-46).

Zuletzt aktualisiert 2017-15-10 um 02:01